Label: NARS RADIANCE PRIMER BROAD SPECTRUM SPF 35 SUNSCREEN- octisalate, octocrylene, avobenzone, homosalate lotion
- NDC Code(s): 68577-159-01
- Packager: COSMAX USA, CORPORATION
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 25, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- USES
- Warnings
-
DIRECTIONS
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
Sun Protection Measures.
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:limit time in the sun, especially from 10 a.m. - 2 p.m.
wear long-sleeve shirts, pants, hats, and sunglasses- children under 6 months: Ask a doctor
-
INACTIVE INGREDIENT
Inactive ingredients:
Water ∙ Caprylyl Methicone ∙ Dipropylene Glycol ∙ Propanediol ∙ Dimethicone ∙ Butyloctyl Salicylate ∙ Lactobacillus Ferment ∙ Isododecane ∙ Ammonium Acryloyldimethyltaurate/VP Copolymer ∙ Trisiloxane ∙ Polysorbate 60 ∙ Trimethylsiloxysilicate ∙ Dextrin Palmitate ∙ Phenoxyethanol ∙ C14-22 Alcohols ∙ Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer ∙ Hydrolyzed Wheat Protein/PVP Crosspolymer ∙ Panthenol ∙ Fragrance ∙ Evodia Rutaecarpa Fruit Extract ∙ Dibutyl Ethylhexanoyl Glutamide ∙ Dibutyl Lauroyl Glutamide ∙ Disodium EDTA ∙ C12-20 Alkyl Glucoside ∙ Dipotassium Glycyrrhizate ∙ Tocopheryl Acetate ∙ Sodium Hyaluronate ∙ Butylene Glycol ∙ Pentylene Glycol ∙ Tin Oxide ∙ Potassium Sorbate ∙ Hydroxyphenyl Propamidobenzoic Acid ∙ Ethylhexylglycerin ∙ Ascorbyl Palmitate ∙ Mica ∙ Titanium Dioxide ∙ Red 4 ∙ Yellow 5 ∙
- OTHER INFORMATION
- QUESTIONS or COMMENTS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
NARS RADIANCE PRIMER BROAD SPECTRUM SPF 35 SUNSCREEN
octisalate, octocrylene, avobenzone, homosalate lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68577-159 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 2 mg in 100 mg HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 6 mg in 100 mg OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 1.6 mg in 100 mg OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 5 mg in 100 mg Inactive Ingredients Ingredient Name Strength C12-20 ALKYL GLUCOSIDE (UNII: K67N5Z1RUA) FD&C RED NO. 4 (UNII: X3W0AM1JLX) GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX) PENTYLENE GLYCOL (UNII: 50C1307PZG) ASCORBYL PALMITATE (UNII: QN83US2B0N) ISODODECANE (UNII: A8289P68Y2) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) DIBUTYL LAUROYL GLUTAMIDE (UNII: 3V7K3IA58X) DEXTRIN PALMITATE (CORN; 20000 MW) (UNII: 89B2BSF9I3) HYALURONATE SODIUM (UNII: YSE9PPT4TH) TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN) PROPANEDIOL (UNII: 5965N8W85T) STANNIC OXIDE (UNII: KM7N50LOS6) CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL) WATER (UNII: 059QF0KO0R) DIMETHICONE (UNII: 92RU3N3Y1O) TRISILOXANE (UNII: 9G1ZW13R0G) PHENOXYETHANOL (UNII: HIE492ZZ3T) HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4) PANTHENOL (UNII: WV9CM0O67Z) EDETATE DISODIUM (UNII: 7FLD91C86K) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) LIMOSILACTOBACILLUS REUTERI (UNII: 9913I24QEE) C14-22 ALCOHOLS (UNII: B1K89384RJ) TETRADIUM RUTICARPUM FRUIT (UNII: Q413WWJ3X9) AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG) HYDROXYPHENYL PROPAMIDOBENZOIC ACID (UNII: 25KRT26H77) DIPROPYLENE GLYCOL (UNII: E107L85C40) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) POLYSORBATE 60 (UNII: CAL22UVI4M) DIBUTYL ETHYLHEXANOYL GLUTAMIDE (UNII: 0IAF2L30VS) FD&C YELLOW NO. 5 (UNII: I753WB2F1M) MICA (UNII: V8A1AW0880) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68577-159-01 1 in 1 CARTON 06/01/2023 1 30 mg in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 06/01/2023 Labeler - COSMAX USA, CORPORATION (010990210) Registrant - COSMAX USA, CORPORATION (010990210) Establishment Name Address ID/FEI Business Operations COSMAX USA. CORPORATION 010990210 manufacture(68577-159)